CDC report shows decrease in US tobacco product use

Mar.23.2022
CDC report shows decrease in US tobacco product use
CDC's survey showed a decrease in overall tobacco product usage among American adults, but 19% still use some form of tobacco.

According to foreign media on March 17, 2022, report that...

 

The Centers for Disease Control and Prevention (CDC) released the findings of their weekly report on incidence and mortality rates today, revealing an overall decrease in the use of commercial tobacco products, combustible tobacco products, cigarettes, e-cigarettes, and two or more tobacco products among U.S. adults from 2019 to 2020. However, as of 2020, nearly one-fifth of adults (estimated 47.1 million) reported current (daily or some days) tobacco product use, including 30.8 million smokers.

 

In order to assess recent estimates of tobacco product use among adult Americans aged 18 and over, the Center for Disease Control and Prevention (CDC) analyzed data from the 2020 National Health Interview Survey. The survey evaluated the use of five tobacco products: cigarettes, cigars (cigars, small cigars, or filtered little cigars), pipes (regular pipes, water pipes, or hookahs), electronic cigarettes, and smokeless tobacco.

 

A recent study has found that by 2020, 19.0% of American adults will have used at least one tobacco product, which is slightly lower than the 20.8% reported in 2019. Despite this decrease, cigarettes remain the most commonly used product at 12.5%, followed by e-cigarettes at 3.7%, cigars at 3.5%, smokeless tobacco at 2.3%, and pipes at 1.1%.

 

We have made significant progress in preventing and reducing tobacco use in this country through the use of validated strategies and implementation of effective policies," said Dr. Karen Hacker, director of the CDC's National Center for Chronic Disease Prevention and Health Promotion. "Although adult tobacco use has dramatically decreased, our work is far from over. We must continue to address tobacco-related health disparities and inequities to ensure that everyone has the opportunity to be as healthy as possible.

 

Despite a decrease, the usage of combustible products remains high.

 

A new study reveals that smoking rates among adults have dropped to their lowest point since 1965, when it was 42%. While the percentage of adults who smoke has decreased from 14.0% in 2019 to 12.5% in 2020, nearly 31 million American adults still reported smoking in 2020. Among adults who currently use tobacco products, over three-quarters use combustible products like cigarettes, cigars, and pipes, which are the leading cause of tobacco-related illness, disability, and death in the United States.

 

In the United States, between 2019 and 2020, there was a decrease in the percentage of adults using other tobacco products, including e-cigarettes, which went from 4.5% to 3.7%. The use of combustible tobacco products also decreased from 16.7% to 15.2%. Additionally, the percentage of people using two or more tobacco products also decreased from 3.9% to 3.3%.

 

Factors that may contribute to a decline in smoking and tobacco use include influential anti-tobacco media campaigns such as the CDC's "Tips From Former Smokers," smoke-free policies, and policies that restrict the supply of specific types of tobacco products, such as flavored products.

 

Differences in the use of tobacco products

 

By 2020, significant differences still exist in the use of tobacco products among various adult population groups in the United States. These groups include:

 

Men (5%).

 

Nine percent of adults aged 25 to 44 years old.

 

34.9% of adult non-Hispanic American Indian/Alaska Native individuals and 1% of adult non-Hispanic individuals are classified as belonging to other races.

 

Three percent of adults live in rural (non-urban) areas.

 

The highest level of education attained by adults is a General Educational Development (GED) certificate, which accounts for 40.5%.

 

25.2% of adults have a household annual income less than $35,000.

 

Adults who identify as lesbian, gay, or bisexual (1%).

 

27.3% of adults do not have health insurance, while 6% rely on Medicaid or other forms of subsidized health insurance.

 

Four percent of adults have disabilities.

 

Nearly 30% of adults experience anxiety and 6% experience depression on a regular basis.

 

(Source: Center for Disease Control)

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives